Komori
Treasury Shares6090Human Metabolome Technologies,Inc.Information and Communications, Services and Others

Notice Regarding the Status of Share Repurchases

In April 2026, the company acquired 9,800 treasury shares through market purchases. Cumulative acquisitions based on the board resolution reached 73,700 shares, with a cumulative acquisition cost of ¥52,954,600.

Worth reading
43Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Neutral
Direction inferred from the company’s description.
Scale
6894800
¥
Wording
Definitive
How definitive the wording is.

Progress against acquisition limit

Market purchases on the Tokyo Stock Exchange

Resolved 12 February 2026 / Acquisition period 13 February 2026 to 31 December 2026

29.5%
Cumulative utilization rate
Limit176,300 株 remaining
Number of Shares250,000 shares (maximum)
—
No Track Record Reported
Limit
Amount¥200 million (maximum)

The darker band is the portion acquired this time (1 April 2026 to 30 April 2026 (based on trade date)).

Number of Shares
Limit250,000 shares (maximum)
Cumulative total73,700 shares (as of 30 April 2026)
Current9,800 shares
Amount
Limit¥200 million (maximum)
Cumulative total¥52,954,600 (as of 30 April 2026)
Current¥6,894,800
Percentage of total issued shares4.4%
Average acquisition price for this transaction (calculated)¥704 per shareCurrent acquisition price ÷ current number of shares acquired

消化率と残りは、会社が示した累計・今回と上限から算出しています。進捗率=上限に対してどこまで使ったかの割合です。

Progress against acquisition limit
ItemDetails
Total number of shares acquired in this transaction9,800 shares
Total current acquisition price¥6,894,800
Acquisition date/acquisition period1 April 2026 to 30 April 2026 (based on trade date)
Method of acquisitionMarket purchases on the Tokyo Stock Exchange
Cumulative number of shares acquired73,700 shares (as of 30 April 2026)
Cumulative acquisition cost¥52,954,600 (as of 30 April 2026)
Resolution date12 February 2026
Maximum number of shares to be acquired250,000 shares (maximum)
Total acquisition price¥200 million (maximum)
Acquisition period under the resolution13 February 2026 to 31 December 2026
Percentage of total issued shares4.4%
Items this document does not state (2)
Whether acquisition has been completedAverage Acquisition Price

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The company is reporting the acquisition of treasury shares and the status of the acquisitions, but no reason for the acquisitions is stated.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Regarding the Status of Share Repurchases | Human Metabolome Technologies,Inc. (6090) timely disclosure | Komori